Journal article
Vaccination History and Risk of Lymphoma and Its Major Subtypes
Cancer epidemiology, biomarkers & prevention, Vol.31(2), pp.461-470
02/2022
DOI: 10.1158/1055-9965.EPI-21-0383
PMCID: PMC8825700
PMID: 34782394
Abstract
Vaccinations have been hypothesized to play a role in lymphoma etiology, but there are few studies, mixed results, and limited data on lymphoma subtypes. Herein, we investigate the association of vaccinations with risk of major lymphoma subtypes.
We studied 2,461 lymphoma cases and 2,253 controls enrolled from 2002 to 2014. Participants self-reported history of vaccinations against hepatitis A, hepatitis B, yellow fever, and influenza. Polytomous logistic regression was used to estimate OR and 95% confidence intervals (CI), adjusting for potential confounders.
After multivariable adjustment, vaccination against influenza was inversely associated with lymphoma (OR = 0.82; 95% CI, 0.66-1.02), which was stronger for last vaccination 1+ years before enrollment (OR = 0.71; 95% CI, 0.56-0.91) and for >5 influenza vaccinations (OR = 0.56; 95% CI, 0.46-0.68). Ever vaccination against hepatitis A (OR = 0.81; 95% CI, 0.66-1.00) but not hepatitis B (OR = 0.97; 95% CI, 0.81-1.18) was associated with lymphoma risk, although more recent vaccinations were inversely associated with lymphoma risk for both hepatitis A (<6 years before enrollment, OR = 0.56; 95% CI, 0.40-0.77) and hepatitis B (<9 years before enrollment, OR = 0.72; 95% CI, 0.55-0.93). Ever vaccination against yellow fever was inversely associated with risk (OR = 0.73; 95% CI, 0.55-0.96), and this did not vary by time since last vaccination. Although there was no overall statistical evidence for heterogeneity of vaccination history by lymphoma subtype, the only statistically significant inverse associations were observed for influenza and yellow fever vaccinations with diffuse large B-cell and follicular lymphoma.
Selected vaccinations were inversely associated with lymphoma risk, with time since last vaccination relevant for some of these vaccines.
Vaccinations against hepatitis A, hepatitis B, yellow fever, and influenza are unlikely to increase lymphoma risk.
Details
- Title: Subtitle
- Vaccination History and Risk of Lymphoma and Its Major Subtypes
- Creators
- Geffen Kleinstern - University of HaifaMelissa C Larson - Mayo ClinicStephen M Ansell - Division of Hematology, Mayo Clinic.Carrie A Thompson - Mayo ClinicGrzegorz S Nowakowski - Mayo ClinicTimothy G Call - Mayo ClinicDennis P Robinson - Mayo ClinicMatthew J Maurer - Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MinnesotaRaphael Mwangi - Mayo ClinicAndrew L Feldman - Laboratory Medicine and Pathology, Mayo ClinicNeil E Kay - Mayo ClinicAnne J Novak - Division of Hematology, Mayo Clinic.Thomas M Habermann - Division of Hematology, Mayo Clinic.Susan L Slager - Mayo ClinicJames R Cerhan - Mayo Clinic
- Resource Type
- Journal article
- Publication Details
- Cancer epidemiology, biomarkers & prevention, Vol.31(2), pp.461-470
- DOI
- 10.1158/1055-9965.EPI-21-0383
- PMID
- 34782394
- PMCID
- PMC8825700
- NLM abbreviation
- Cancer Epidemiol Biomarkers Prev
- ISSN
- 1055-9965
- eISSN
- 1538-7755
- Grant note
- R01 CA092153 / NCI NIH HHS P30 CA015083 / NCI NIH HHS P50 CA097274 / NCI NIH HHS
- Language
- English
- Date published
- 02/2022
- Academic Unit
- Epidemiology
- Record Identifier
- 9984368084902771
Metrics
15 Record Views